期刊文献+

阿米替林聚氰基丙烯酸正丁酯纳米粒对卒中后抑郁大鼠的治疗 被引量:1

Therapy with AMI-PBCA-NP for post-shock depression in rat
下载PDF
导出
摘要 目的研究阿米替林聚氰基丙烯酸正丁酯纳米粒(AMI-PBCA-NP)对卒中后抑郁(PSD)大鼠的疗效。方法 32只PSD大鼠随即分为4组:对照组、阿米替林(AMI)组、舍曲林组和AMI-PBCA-NP组,分别腹腔注射生理盐水、AMI水溶液、舍曲林水溶液、AMI-PBCA-NP乳液对PSD大鼠进行14d治疗,观察治疗前后大鼠体重、糖水实验、敞箱实验、多导睡眠图等变化。结果①AMI-PBCA-NP组大鼠在蔗糖水饮用量上增多,较对照组、AMI组和舍曲林组,差异有显著性(P<0.05);②AMI-PBCA-NP组大鼠Open-Field水平运动次数、垂直运动次数增多,较对照组、AMI组和舍曲林组差异有显著性(P<0.05);③AMI-PBCA-NP组大鼠多导睡眠图测定在快眼动睡眠(REM)时间和潜伏期增多,较对照组、AMI组和舍曲林组差异有显著性(P<0.05)。结论 AMI-PBCA-NP治疗PSD大鼠疗效较AMI、舍曲林显著。 ObjectiveTo study the curative effect of AMI-PBCA-NP on post-shock depression(PSD) in rats.MethodsThirty-two PSD rats were randomly assigned to control group,AMI group,sertraline group and AMIPBCA-NP group.And they were treated by intraperitoneal injection of saline,AMI,sertraline and AMI-PBCA-NP respectively for about 14 days.Then the changes in weight,sucrose solution consumption test,open-field test and polysomnogram were investigated.Results①Compared with control group,sucrose solution consumption increased in AMI,sertraline group and AMI-PBCA-NP groups.The differences were significant(P 0.05).②Compared with control group,both horizontal and vertical movement increased in AMI,sertraline group and AMI-PBCA-NP groups.The differences were significant(P 0.05).③Compared with control group,REM time,REM latency increased in AMI,sertraline group and AMI-PBCA-NP groups.The differences were significant(P 0.05).ConclusionThe efficacy of AMI-PBCA-NP therapy for PSD is better than that of AMI and sertraline.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第17期2604-2606,2611,共4页 China Journal of Modern Medicine
基金 河南省医学科技攻关重点项目(No:200902008) 河南省医学科技攻关项目(No:200803082)
关键词 阿米替林 卒中 抑郁 多导睡眠图 舍曲林 纳米粒 amitriptyline PSD polysomnogram sertraline nanoparticles
  • 相关文献

参考文献8

二级参考文献34

  • 1漆红,赵友文,李美琳.脑血管病后抑郁的临床特点及相关因素[J].中国心理卫生杂志,1995,9(3):121-123. 被引量:84
  • 2KREUTER J. Nanoparticulate systems for brain delivery of drugs [J].AdvDrug Deliv Rev, 2001,47(1):65-81. 被引量:1
  • 3ALYAUTDIN RN, REICHEL A, LOBENBERG R, et al. Interaction of poly-butylcyanoacrylate nanoparticles with the blood-brain barrier in vivo and in vitro[J].J Drug Target, 2001,9(3):209-221. 被引量:1
  • 4LOCKMAN PR, MUMPER RJ, KHAN MA, et al. Nanoparticle technology for drug delivery across the blood-brain barrier[J].Drug Dev Ind Pharm,2002,28:1-13. 被引量:1
  • 5COUVREUR P, KANTE B, ROLAND M, et al. Adsorption of anfineoplastic drugs topolyalkylcyanoacrylate nanoparticles and their release in calf serum[J]. PharmSci,1979,68(12):1521-1524. 被引量:1
  • 6YOUNG-II JEONG, MYUNG-KI KANG, HEUNG-SUK SUN, et al. All-trans-retinoic acid releade from core-shell type nanopartides of poly(caprolactone)/poly(ethyleneglycol) diblock copolymer [J].Int J Phaim,2004,27(3):95-107. 被引量:1
  • 7YOO SUNG NAM, KIL JOONG KIM, HYIMG SEOK KANG, et al. Chemical Immobilization of Retinoic Acid within Poly(eaprolactone) Nanopartides Based on Drug-Polymer Bioeonjugates[J] .J of Appl Polymer Science,,2003,89: 1631-1637. 被引量:1
  • 8H.S.LIN BSC, CS CHEAN BSC, YY NG BSC, et al. 2-Hydroxypropyl-o-cyelodextrin inereas aqueous solubility and photostability of all-trans-refinoicacid [J]. Int. J of Clinical and Therapeutics, 2000,(25):265-269. 被引量:1
  • 9C.DUCLAIROIR, A.M.ORECCHION, P.DEPRACTERE, FO STERSTOCK,et al. Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs[J]. Int J Pharm, 2003,253:133-144. 被引量:1
  • 10K.KRAUEL, N.M.DAVIES, S.HOOK, et al. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate)nanoparticles by interfacialpolymerization. [J]Journal of Controlled Release,2005,106(1-2):76-87. 被引量:1

共引文献59

同被引文献36

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部